Type 2 Diabetes in CKD: Improving Cardio-Renal Outcomes

Home
»
2024 National Conference
»
Product Details

You must select a location to proceed.

Yes

There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.

Adding Registration, Please wait...

You must be logged in to perform this action.

Cancel

Type 2 Diabetes in CKD: Improving Cardio-Renal Outcomes

Recorded for 2024 National Conference

Credit(s):

1.05 Contact Hour(s) of CE; 0.37 of which may be applied towards Pharmacology

Program Number:

24066669

Original Program Date:

June 26, 2024

Duration:

1 hour 2 minutes

Access:

Available until July 15, 2025

Special Offer

Click here to see Special Offer(s)!

Facebook

Twitter

E-Mail

Description
Sessions
Credits
Faculty
Materials
Reviews
Dates and Locations

(136)

Read Reviews

Category: 2024 National Conference, Adult-Gerontology, Cardiometabolic ... (show more)

Category: 2024 National Conference, Adult-Gerontology, Cardiometabolic, Cert Exam Domain - Diagnosis, Cert Exam Domain - Evaluation, Cert Exam Domain - Planning, Diabetes, Diabetes Mellitus, Endocrine, Nephrology, Recent Additions (show less)

Activity Duration

Content Expires:

July 15, 2025 (11:55 p.m. CT)
CE for this activity will not be available after this date.

This CE activity was recorded for the 2024 AANP National Conference.

This activity includes closed captioning.

Delivery Note: The content for this activity was previously presented during the 2024 AANP National Conference. If you already completed the content of this activity while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies.

Overview
Diabetes and chronic kidney disease (CKD) are two prevalent conditions that often co-exist, and each is associated with increased cardiovascular risk. Diabetes is the leading cause of CKD. This presentation will discuss the pharmacological and lifestyle management of adults with diabetes and CKD. Approaches to improve cardio-renal outcomes beyond glycemic control will also be addressed. More specifically, this session will focus on the management of the T2DM patient with an emphasis on cardio-renal pharmacological management. After a review of the multiple complex pathophysiological abnormalities of T2DM, various cardio-renal medication options will be explored with case application. The value of this presentation will be to explore the 'sea of options' and to determine the best therapeutic approach for individual patients. The goal of this presentation is to advance T2DM cardiorenal therapy with confidence since getting to the goal can be difficult.

Objectives

Identify at least 3 (three) complex, pathophysiological abnormalities of type 2 diabetes mellitus (T2DM) for a greater understanding of the impact on management.
Apply at least three (3) evidence-based strategies to improve cardio/renal outcomes in patients with Type 2 Diabetes and CKD.
Describe at least three (3) pharmacological approaches to manage the Type 2 Diabetes in CKD.
Discuss at least three (3) concrete lifestyle interventions for patients with Type 2 Diabetes and CKD.

Speaker
Kathleen P. Wilson, PhD, APRN, FNP-BC, BC-ADM, FAANP, FNAP, DipACLM

Disclosure
This program was planned in accordance with AANP CE Standards and Policies.

The speaker has the following disclosures:

No relevant relationships to disclose.

Disclaimer
Individuals who have contributed to the CE Center (content originally from the 2024 AANP National Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

CE Credit Instructions

Read this activity description, including objectives and disclosures.
Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
  - A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
  - A copy of the certificate will be automatically added to your AANP CE Tracker.

Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.

1.05 Contact Hour(s) of CE,
0.37 of which may be applied towards Pharmacology